BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 10586235)

  • 1. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P0 mRNA expression in cultures of Schwann cells and neurons that lack basal lamina and myelin.
    Brunden KR; Brown DT
    J Neurosci Res; 1990 Oct; 27(2):159-68. PubMed ID: 1701492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetics of myelination: an update.
    Lemke G
    Glia; 1993 Apr; 7(4):263-71. PubMed ID: 7686535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
    Kuhn G; Lie A; Wilms S; Müller HW
    Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis of inherited peripheral neuropathies.
    Suter U; Patel PI
    Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication.
    Timmerman V; Nelis E; Van Hul W; Nieuwenhuijsen BW; Chen KL; Wang S; Ben Othman K; Cullen B; Leach RJ; Hanemann CO
    Nat Genet; 1992 Jun; 1(3):171-5. PubMed ID: 1303230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
    Bosse F; Zoidl G; Wilms S; Gillen CP; Kuhn HG; Müller HW
    J Neurosci Res; 1994 Mar; 37(4):529-37. PubMed ID: 8021974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of fast axonal transport in vivo leads to alterations in Schwann cell gene expression.
    Wu W; Toma JG; Chan H; Smith R; Miller FD
    Dev Biol; 1994 Jun; 163(2):423-39. PubMed ID: 7515362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of axons in the regulation of P0 biosynthesis by Schwann cells.
    Brunden KR; Windebank AJ; Poduslo JF
    J Neurosci Res; 1990 Jun; 26(2):135-43. PubMed ID: 1694900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene.
    Hayasaka K; Himoro M; Sato W; Takada G; Uyemura K; Shimizu N; Bird TD; Conneally PM; Chance PF
    Nat Genet; 1993 Sep; 5(1):31-4. PubMed ID: 7693129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation of the myelin Po gene in hereditary motor and sensory neuropathy].
    Hayasaka K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1444-6. PubMed ID: 8752425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for an early role for myelin-associated glycoprotein in the process of myelination.
    Owens GC; Bunge RP
    Glia; 1989; 2(2):119-28. PubMed ID: 2470674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutation of the myelin P0 gene in a pedigree of Charcot-Marie-Tooth neuropathy 1.
    Himoro M; Yoshikawa H; Matsui T; Mitsui Y; Takahashi M; Kaido M; Nishimura T; Sawaishi Y; Takada G; Hayasaka K
    Biochem Mol Biol Int; 1993 Sep; 31(1):169-73. PubMed ID: 7505151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP.
    Weinstein DE; Burrola PG; Lemke G
    Mol Cell Neurosci; 1995 Jun; 6(3):212-29. PubMed ID: 7496628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
    Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
    Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties.
    Schneider-Schaulies J; von Brunn A; Schachner M
    J Neurosci Res; 1990 Nov; 27(3):286-97. PubMed ID: 1711125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
    Yoshikawa H; Nishimura T; Yanagihara T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.